Tweetovi

Blokirali ste korisnika/cu @AlvinLuk_Health

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AlvinLuk_Health

  1. 5. velj

    Cell Research published anti-nCoV drug screening report with cell-based assay today. is used in RA and in can also suppress nCoV as I checked EC50 to kill the is 1130nM. I think 600mgQDx14days may infection! Am I crazy 😜?

    Poništi
  2. 2. velj

    We’ve expedited to develop appropriate laboratory testing of (瑞德西韦) against and initiate a , controlled of 270 patients expecting to begin tonight (03Feb) in while our effort continues to develop for

    Poništi
  3. 29. ruj 2019.

    Honor to present at on HLX02 which met primary endpoint with no clinically meaningful difference from (80K€/pt). Results were filed to China & for approvals. Beyond cost benefits, use of HLX02 may provide patient benefit!

    Poništi
  4. 18. ruj 2019.

    I have done IPO in US only and 复宏汉霖 | Henlius IPO in HKG has provided me valuable experience dealing with analysts, asset management and investment portfolio management in China, Hong Kong, USA and UK!

    Poništi
  5. 11. ruj 2019.
    Poništi
  6. 22. kol 2019.
    Poništi
  7. proslijedio/la je Tweet

    Please join me, , & and many other leaders in signing this letter on the threat to biomedical progress if we do not guard against generalized suspicion of Chinese scientists.

    Poništi
  8. 20. srp 2019.

    7 Argentinians (aged 14-21 years) with Leber () went to to be part of the -ND4 clinical trial for their . Time to think about getting gene therapy treatment in China?

    Poništi
  9. 20. srp 2019.

    will make or break each investment opportunity in the space — proving even more important than successful results.”

    Poništi
  10. 12. srp 2019.

    The pathway has an important role in inhibiting the function of virus-specific CD8+ in chronic , , and infection. The PD-1 expression level on CD4+ T cells was elevated in chronic HBV-infected patients but…

    Poništi
  11. 27. lip 2019.

    Waiting for the sunset while sipping on cocktails...... @ Lisbon, Portugal

    Poništi
  12. 22. lip 2019.

    First night in and we decided to go to / . The cocktails are the killers! You will go to heaven by trying their and a bottle…

    Poništi
  13. 21. lip 2019.

    International Society on Thrombosis and Haemostasis (ISTH) oral sessions uniQure on , Sangamo Therapeutics, Inc. on and Spark Therapeutics, Inc. on .

    Poništi
  14. 18. lip 2019.
    Poništi
  15. 6. lip 2019.

    Thanks to the advances in manufacturing technology and gene sequencing, and cell/ have made it possible. therapy, immunotherapy, CAR-T and gene therapy can be expensive and none of the current approved therapy…

    Poništi
  16. 6. lip 2019.

    Thanks to advances in manufacturing technology and gene sequencing, affordable biologics and cell/ have made it possible. Antibody therapy, immunotherapy, CAR-T and gene therapy can be expensive and none of the current approved therapy is tar…

    Poništi
  17. 5. lip 2019.

    It’s in great honor to review potential products from CHOP - a goal to allow effective therapy be beneficial not only US and EU but rest of the world!

    Poništi
  18. 25. svi 2019.

    Gene therapy has the potential to reimagine the future of rare and devastating diseases. The Institute for Clinical and Economic Review agreed for $2,100,000 USD on to treat a fatal SMA disease while FDA approved

    Poništi
  19. 11. ožu 2019.

    China NMPA approved Shanghai 1st . Roche recently took a 40% price cut on reference product for NRDL reimbursement in 2017. Henlius is also developing and other biosimilars.

    Poništi
  20. proslijedio/la je Tweet
    6. velj 2019.

    Some biosimilars are just as good as some pricey biologics via

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·